Search research articles
Contact Us
Filters
Showing results (61-70 of 103) with videos related to
Page
of 11
Sort By:
ACS Medicinal Chemistry Letters
|
October 20, 2022
Virtual Special Issue: Epigenetics 2022
Courtney C Aldrich, Félix Calderón, Stuart J Conway, et al.
ACS Infectious Diseases
|
September 8, 2022
Virtual Special Issue: Epigenetics 2022
Courtney C Aldrich, Félix Calderón, Stuart J Conway, et al.
ACS Chemical Biology
|
April 20, 2013
CH-01 is a hypoxia-activated prodrug that sensitizes cells to hypoxia/reoxygenation through inhibition of Chk1 and Aurora A
Cindy Cazares-Körner, Isabel M Pires, I Diane Swallow, et al.
Metabolites
|
July 2, 2021
Bioactivation of Isoxazole-Containing Bromodomain and Extra-Terminal Domain (BET) Inhibitors
Noah R Flynn, Michael D Ward, Mary A Schleiff, et al.
Nature Communications
|
August 2, 2019
Engineering transkingdom signalling in plants to control gene expression in rhizosphere bacteria
Barney A Geddes, Ponraj Paramasivan, Amelie Joffrin, et al.
Biochemistry
|
March 8, 2014
Understanding the structural requirements for activators of the Kef bacterial potassium efflux system
Jessica Healy, Silvia Ekkerman, Christos Pliotas, et al.
Cell Calcium
|
May 28, 2003
2-Aminoethoxydiphenyl borate (2-APB) antagonises inositol 1,4,5-trisphosphate-induced calcium release, inhibits calcium pumps and has a use-dependent and slowly reversible action on store-operated calcium entry channels
Claire M Peppiatt, Tony J Collins, Lauren Mackenzie, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
November 17, 2025
High-Affinity Peptide-Drug Conjugate Ligands for the TRIM24 PHD and Bromodomain
Michael A Platt, Ekaterina Kot, Louise A W Martin, et al.
Organic & Biomolecular Chemistry
|
August 27, 2009
Synthesis and biological evaluation of a novel cardiolipin affinity matrix
Melloney K Johns, Meng-Xin Yin, Stuart J Conway, et al.
ACS Infectious Diseases
|
October 31, 2023
Bromodomain Factor 5 as a Target for Antileishmanial Drug Discovery
Catherine N Russell, Jennifer L Carter, Juliet M Borgia, et al.
Page
of 11
Search research articles
Search
Showing results (61-70 of 103) with videos related to
Sort By:
Page
of 11
ACS Medicinal Chemistry Letters
|
October 20, 2022
Virtual Special Issue: Epigenetics 2022
Courtney C Aldrich, Félix Calderón, Stuart J Conway, et al.
ACS Infectious Diseases
|
September 8, 2022
Virtual Special Issue: Epigenetics 2022
Courtney C Aldrich, Félix Calderón, Stuart J Conway, et al.
ACS Chemical Biology
|
April 20, 2013
CH-01 is a hypoxia-activated prodrug that sensitizes cells to hypoxia/reoxygenation through inhibition of Chk1 and Aurora A
Cindy Cazares-Körner, Isabel M Pires, I Diane Swallow, et al.
Metabolites
|
July 2, 2021
Bioactivation of Isoxazole-Containing Bromodomain and Extra-Terminal Domain (BET) Inhibitors
Noah R Flynn, Michael D Ward, Mary A Schleiff, et al.
Nature Communications
|
August 2, 2019
Engineering transkingdom signalling in plants to control gene expression in rhizosphere bacteria
Barney A Geddes, Ponraj Paramasivan, Amelie Joffrin, et al.
Biochemistry
|
March 8, 2014
Understanding the structural requirements for activators of the Kef bacterial potassium efflux system
Jessica Healy, Silvia Ekkerman, Christos Pliotas, et al.
Cell Calcium
|
May 28, 2003
2-Aminoethoxydiphenyl borate (2-APB) antagonises inositol 1,4,5-trisphosphate-induced calcium release, inhibits calcium pumps and has a use-dependent and slowly reversible action on store-operated calcium entry channels
Claire M Peppiatt, Tony J Collins, Lauren Mackenzie, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
November 17, 2025
High-Affinity Peptide-Drug Conjugate Ligands for the TRIM24 PHD and Bromodomain
Michael A Platt, Ekaterina Kot, Louise A W Martin, et al.
Organic & Biomolecular Chemistry
|
August 27, 2009
Synthesis and biological evaluation of a novel cardiolipin affinity matrix
Melloney K Johns, Meng-Xin Yin, Stuart J Conway, et al.
ACS Infectious Diseases
|
October 31, 2023
Bromodomain Factor 5 as a Target for Antileishmanial Drug Discovery
Catherine N Russell, Jennifer L Carter, Juliet M Borgia, et al.
Page
of 11